Ontology type: schema:ScholarlyArticle
2013-12-19
AUTHORSJun Liang, Jianwu Xi, Huijuan Pan, Ying Qian, Dan Xu, Min Li
ABSTRACTObjectiveThe aim of this study was to evaluate effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer.MethodsFourteen cases of patients diagnosed with non-small cell lung cancer (NSCLC), the use of the B-, CT-guided, according to preoperative imaging and treatment planning system (TPS) program for radioactive particles interposed 125I interstitial radiotherapy.ResultsAll patients were successfully 125I interstitial radioactive particles interposed radiotherapy. Postoperative local complete tumor remission in 9 cases, partial remission in 5 cases, the efficiency of 100%. No case of serious complications. After 3 to 4 weeks of chemotherapy after 11 cases. 4 cases of lung cancer with bone metastases, pain completely disappeared after treatment. Up to now, five cases have died due to tumor progression, survival time of 12 to 16 months. Nine cases still under follow-up observation and treatment.Conclusion125I radioactive particles interposed radiotherapy between organizations of lung cancer, simple operation, trauma, fewer complications, conformal high, high local tumor dose, efficacy, and is a supplement of modern radiotherapy techniques for the treatment of lung cancer provides a comprehensive line of the method of effective. More... »
PAGES564-567
http://scigraph.springernature.com/pub.10.1007/s10330-013-1245-4
DOIhttp://dx.doi.org/10.1007/s10330-013-1245-4
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1048045179
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
],
"type": "Organization"
},
"familyName": "Liang",
"givenName": "Jun",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
],
"type": "Organization"
},
"familyName": "Xi",
"givenName": "Jianwu",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
],
"type": "Organization"
},
"familyName": "Pan",
"givenName": "Huijuan",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
],
"type": "Organization"
},
"familyName": "Qian",
"givenName": "Ying",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
],
"type": "Organization"
},
"familyName": "Xu",
"givenName": "Dan",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
],
"type": "Organization"
},
"familyName": "Li",
"givenName": "Min",
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s10330-006-0029-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1003749079",
"https://doi.org/10.1007/s10330-006-0029-5"
],
"type": "CreativeWork"
}
],
"datePublished": "2013-12-19",
"datePublishedReg": "2013-12-19",
"description": "ObjectiveThe aim of this study was to evaluate effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer.MethodsFourteen cases of patients diagnosed with non-small cell lung cancer (NSCLC), the use of the B-, CT-guided, according to preoperative imaging and treatment planning system (TPS) program for radioactive particles interposed 125I interstitial radiotherapy.ResultsAll patients were successfully 125I interstitial radioactive particles interposed radiotherapy. Postoperative local complete tumor remission in 9 cases, partial remission in 5 cases, the efficiency of 100%. No case of serious complications. After 3 to 4 weeks of chemotherapy after 11 cases. 4 cases of lung cancer with bone metastases, pain completely disappeared after treatment. Up to now, five cases have died due to tumor progression, survival time of 12 to 16 months. Nine cases still under follow-up observation and treatment.Conclusion125I radioactive particles interposed radiotherapy between organizations of lung cancer, simple operation, trauma, fewer complications, conformal high, high local tumor dose, efficacy, and is a supplement of modern radiotherapy techniques for the treatment of lung cancer provides a comprehensive line of the method of effective.",
"genre": "article",
"id": "sg:pub.10.1007/s10330-013-1245-4",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1032171",
"issn": [
"1610-1979",
"1613-9089"
],
"name": "The Chinese-German Journal of Clinical Oncology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "12",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "12"
}
],
"keywords": [
"non-small cell lung cancer",
"lung cancer",
"weeks of chemotherapy",
"cell lung cancer",
"complete tumor remission",
"modern radiotherapy techniques",
"MethodsFourteen cases",
"ResultsAll patients",
"partial remission",
"bone metastases",
"serious complications",
"preoperative imaging",
"tumor remission",
"interstitial radiotherapy",
"tumor dose",
"survival time",
"radiotherapy techniques",
"radiotherapy",
"tumor progression",
"cancer",
"remission",
"complications",
"patients",
"treatment",
"radioactive particles",
"pain",
"chemotherapy",
"metastasis",
"cases",
"follow",
"trauma",
"dose",
"progression",
"weeks",
"months",
"CT",
"efficacy",
"supplements",
"imaging",
"effect",
"aim",
"mechanism",
"study",
"use",
"program",
"lines",
"organization",
"time",
"observations",
"system program",
"technique",
"method",
"comprehensive line",
"operation",
"simple operation",
"particles",
"efficiency"
],
"name": "Effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer",
"pagination": "564-567",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1048045179"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s10330-013-1245-4"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s10330-013-1245-4",
"https://app.dimensions.ai/details/publication/pub.1048045179"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:28",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_588.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s10330-013-1245-4"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1245-4'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1245-4'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1245-4'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1245-4'
This table displays all metadata directly associated to this object as RDF triples.
148 TRIPLES
22 PREDICATES
83 URIs
74 LITERALS
6 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s10330-013-1245-4 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1112 |
3 | ″ | schema:author | Nd66798edb0b84d409a12d4a4e1781656 |
4 | ″ | schema:citation | sg:pub.10.1007/s10330-006-0029-5 |
5 | ″ | schema:datePublished | 2013-12-19 |
6 | ″ | schema:datePublishedReg | 2013-12-19 |
7 | ″ | schema:description | ObjectiveThe aim of this study was to evaluate effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer.MethodsFourteen cases of patients diagnosed with non-small cell lung cancer (NSCLC), the use of the B-, CT-guided, according to preoperative imaging and treatment planning system (TPS) program for radioactive particles interposed 125I interstitial radiotherapy.ResultsAll patients were successfully 125I interstitial radioactive particles interposed radiotherapy. Postoperative local complete tumor remission in 9 cases, partial remission in 5 cases, the efficiency of 100%. No case of serious complications. After 3 to 4 weeks of chemotherapy after 11 cases. 4 cases of lung cancer with bone metastases, pain completely disappeared after treatment. Up to now, five cases have died due to tumor progression, survival time of 12 to 16 months. Nine cases still under follow-up observation and treatment.Conclusion125I radioactive particles interposed radiotherapy between organizations of lung cancer, simple operation, trauma, fewer complications, conformal high, high local tumor dose, efficacy, and is a supplement of modern radiotherapy techniques for the treatment of lung cancer provides a comprehensive line of the method of effective. |
8 | ″ | schema:genre | article |
9 | ″ | schema:inLanguage | en |
10 | ″ | schema:isAccessibleForFree | false |
11 | ″ | schema:isPartOf | Nb2010c4affaf4392a6cdd5ab7c518657 |
12 | ″ | ″ | Nbd341a9ee6924bc29702901c5cdd3ccc |
13 | ″ | ″ | sg:journal.1032171 |
14 | ″ | schema:keywords | CT |
15 | ″ | ″ | MethodsFourteen cases |
16 | ″ | ″ | ResultsAll patients |
17 | ″ | ″ | aim |
18 | ″ | ″ | bone metastases |
19 | ″ | ″ | cancer |
20 | ″ | ″ | cases |
21 | ″ | ″ | cell lung cancer |
22 | ″ | ″ | chemotherapy |
23 | ″ | ″ | complete tumor remission |
24 | ″ | ″ | complications |
25 | ″ | ″ | comprehensive line |
26 | ″ | ″ | dose |
27 | ″ | ″ | effect |
28 | ″ | ″ | efficacy |
29 | ″ | ″ | efficiency |
30 | ″ | ″ | follow |
31 | ″ | ″ | imaging |
32 | ″ | ″ | interstitial radiotherapy |
33 | ″ | ″ | lines |
34 | ″ | ″ | lung cancer |
35 | ″ | ″ | mechanism |
36 | ″ | ″ | metastasis |
37 | ″ | ″ | method |
38 | ″ | ″ | modern radiotherapy techniques |
39 | ″ | ″ | months |
40 | ″ | ″ | non-small cell lung cancer |
41 | ″ | ″ | observations |
42 | ″ | ″ | operation |
43 | ″ | ″ | organization |
44 | ″ | ″ | pain |
45 | ″ | ″ | partial remission |
46 | ″ | ″ | particles |
47 | ″ | ″ | patients |
48 | ″ | ″ | preoperative imaging |
49 | ″ | ″ | program |
50 | ″ | ″ | progression |
51 | ″ | ″ | radioactive particles |
52 | ″ | ″ | radiotherapy |
53 | ″ | ″ | radiotherapy techniques |
54 | ″ | ″ | remission |
55 | ″ | ″ | serious complications |
56 | ″ | ″ | simple operation |
57 | ″ | ″ | study |
58 | ″ | ″ | supplements |
59 | ″ | ″ | survival time |
60 | ″ | ″ | system program |
61 | ″ | ″ | technique |
62 | ″ | ″ | time |
63 | ″ | ″ | trauma |
64 | ″ | ″ | treatment |
65 | ″ | ″ | tumor dose |
66 | ″ | ″ | tumor progression |
67 | ″ | ″ | tumor remission |
68 | ″ | ″ | use |
69 | ″ | ″ | weeks |
70 | ″ | ″ | weeks of chemotherapy |
71 | ″ | schema:name | Effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer |
72 | ″ | schema:pagination | 564-567 |
73 | ″ | schema:productId | N9d903a7cbb8545689aedc75396c3e0ac |
74 | ″ | ″ | Nf250566d6fdf4293ae279e311f7a19d2 |
75 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1048045179 |
76 | ″ | ″ | https://doi.org/10.1007/s10330-013-1245-4 |
77 | ″ | schema:sdDatePublished | 2022-05-20T07:28 |
78 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
79 | ″ | schema:sdPublisher | N43a3d8e3253a4e4e939cf0aae15f2676 |
80 | ″ | schema:url | https://doi.org/10.1007/s10330-013-1245-4 |
81 | ″ | sgo:license | sg:explorer/license/ |
82 | ″ | sgo:sdDataset | articles |
83 | ″ | rdf:type | schema:ScholarlyArticle |
84 | N21bd4895bb8c4b9dbb2a31be5c7d28bc | rdf:first | Nc5b86b6df3eb4ed3a5467327a028ebdc |
85 | ″ | rdf:rest | rdf:nil |
86 | N29f8a5d4363248f58c5c2e749495c4f8 | rdf:first | N965613604882450baa355e649ad149c3 |
87 | ″ | rdf:rest | N4a186de1f7354d95b952d34fbb873328 |
88 | N43a3d8e3253a4e4e939cf0aae15f2676 | schema:name | Springer Nature - SN SciGraph project |
89 | ″ | rdf:type | schema:Organization |
90 | N4a186de1f7354d95b952d34fbb873328 | rdf:first | N953b2c60ce0644ec99b4c92c589b8f4a |
91 | ″ | rdf:rest | N7a3d6d0f19184491b66bb610f199776c |
92 | N4b003d153d644e5a9ec310bef95170dc | schema:affiliation | grid-institutes:None |
93 | ″ | schema:familyName | Liang |
94 | ″ | schema:givenName | Jun |
95 | ″ | rdf:type | schema:Person |
96 | N7a3d6d0f19184491b66bb610f199776c | rdf:first | N8d176c3ef48d465da15ff82ca421f6c7 |
97 | ″ | rdf:rest | N21bd4895bb8c4b9dbb2a31be5c7d28bc |
98 | N8d176c3ef48d465da15ff82ca421f6c7 | schema:affiliation | grid-institutes:None |
99 | ″ | schema:familyName | Xu |
100 | ″ | schema:givenName | Dan |
101 | ″ | rdf:type | schema:Person |
102 | N953b2c60ce0644ec99b4c92c589b8f4a | schema:affiliation | grid-institutes:None |
103 | ″ | schema:familyName | Qian |
104 | ″ | schema:givenName | Ying |
105 | ″ | rdf:type | schema:Person |
106 | N965613604882450baa355e649ad149c3 | schema:affiliation | grid-institutes:None |
107 | ″ | schema:familyName | Pan |
108 | ″ | schema:givenName | Huijuan |
109 | ″ | rdf:type | schema:Person |
110 | N9d903a7cbb8545689aedc75396c3e0ac | schema:name | dimensions_id |
111 | ″ | schema:value | pub.1048045179 |
112 | ″ | rdf:type | schema:PropertyValue |
113 | Na0c8df5516014b8986f5547301dda4a1 | schema:affiliation | grid-institutes:None |
114 | ″ | schema:familyName | Xi |
115 | ″ | schema:givenName | Jianwu |
116 | ″ | rdf:type | schema:Person |
117 | Nb2010c4affaf4392a6cdd5ab7c518657 | schema:volumeNumber | 12 |
118 | ″ | rdf:type | schema:PublicationVolume |
119 | Nbd341a9ee6924bc29702901c5cdd3ccc | schema:issueNumber | 12 |
120 | ″ | rdf:type | schema:PublicationIssue |
121 | Nc5b86b6df3eb4ed3a5467327a028ebdc | schema:affiliation | grid-institutes:None |
122 | ″ | schema:familyName | Li |
123 | ″ | schema:givenName | Min |
124 | ″ | rdf:type | schema:Person |
125 | Nd66798edb0b84d409a12d4a4e1781656 | rdf:first | N4b003d153d644e5a9ec310bef95170dc |
126 | ″ | rdf:rest | Nfe4167679d23413d9e13d4a9162f1a8e |
127 | Nf250566d6fdf4293ae279e311f7a19d2 | schema:name | doi |
128 | ″ | schema:value | 10.1007/s10330-013-1245-4 |
129 | ″ | rdf:type | schema:PropertyValue |
130 | Nfe4167679d23413d9e13d4a9162f1a8e | rdf:first | Na0c8df5516014b8986f5547301dda4a1 |
131 | ″ | rdf:rest | N29f8a5d4363248f58c5c2e749495c4f8 |
132 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
133 | ″ | schema:name | Medical and Health Sciences |
134 | ″ | rdf:type | schema:DefinedTerm |
135 | anzsrc-for:1112 | schema:inDefinedTermSet | anzsrc-for: |
136 | ″ | schema:name | Oncology and Carcinogenesis |
137 | ″ | rdf:type | schema:DefinedTerm |
138 | sg:journal.1032171 | schema:issn | 1610-1979 |
139 | ″ | ″ | 1613-9089 |
140 | ″ | schema:name | The Chinese-German Journal of Clinical Oncology |
141 | ″ | schema:publisher | Springer Nature |
142 | ″ | rdf:type | schema:Periodical |
143 | sg:pub.10.1007/s10330-006-0029-5 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1003749079 |
144 | ″ | ″ | https://doi.org/10.1007/s10330-006-0029-5 |
145 | ″ | rdf:type | schema:CreativeWork |
146 | grid-institutes:None | schema:alternateName | Department of Oncology, The People’s Hospital Wuxi Huishan Region, 214187, Wuxi, China |
147 | ″ | schema:name | Department of Oncology, The People’s Hospital Wuxi Huishan Region, 214187, Wuxi, China |
148 | ″ | rdf:type | schema:Organization |